Polycystic ovary syndrome is the most common endocrine disorder in reproductive-aged women and characterized by anovulation, hyperandrogenizm, infertility and metabolic disfunction. Basically the presence of 2 of 3 criterias: chronic anovulation, clinical or biochemical evidence of hyperandrogenizm and polycystic ovary morphology have been used for diagnose. Management of polycystic ovary syndrome should be choosed according to the patient’s clinical presentation and fertility state. The clinicians should be careful about the long-term complications such as cardiovascular diseases, type 2 diabetes, metabolic syndrome, gestational diabetes.
Anovulation, hyperandrogenizm, insulin resistance, polycystic ovary syndrome